| Name |
Lumobry 0,25 mg/ml kapi za oko, otopina |
| Marketing Authorisation Number |
HR-H-153563402 |
| Active Substance |
brimonidintartarat |
| Composition |
svaki ml oftalmološke otopine sadrži 0,25 mg (0,025 % m/m) brimonidintartarata (što odgovara 0,0085 mg brimonidintartarata po kapi) |
| Pharmaceutical Form |
Kapi za oko, otopina |
| Manufacturer |
Bausch + Lomb Ireland Limited, Dublin 24, Irska |
| Marketing Authorisation Holder |
Bausch + Lomb Ireland Limited, 3013 Lake Drive, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date |
29.05.2024 |
| MA Period of Validity |
29.05.2029 |
| Classification Number |
UP/I-530-09/23-01/253 |
| Registration Number |
381-12-01/171-24-10 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
S01GA07 |
| Marketing status |
Never marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |
